Page last updated: 2024-10-21

hydroxyindoleacetic acid and Pick Disease of the Brain

hydroxyindoleacetic acid has been researched along with Pick Disease of the Brain in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Pick Disease of the Brain: A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kurihara, M2
Komatsu, H2
Sengoku, R2
Shibukawa, M2
Morimoto, S2
Matsubara, T2
Arakawa, A2
Orita, M2
Ishibashi, K2
Mitsutake, A2
Shibata, S2
Ishiura, H2
Adachi, K2
Ohse, K2
Hatano, K2
Ihara, R2
Higashihara, M2
Nishina, Y2
Tokumaru, AM2
Ishii, K2
Saito, Y2
Murayama, S2
Kanemaru, K2
Iwata, A2

Other Studies

1 other study available for hydroxyindoleacetic acid and Pick Disease of the Brain

ArticleYear
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
    Neurology, 2023, 03-07, Volume: 100, Issue:10

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole

2023
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
    Neurology, 2023, 03-07, Volume: 100, Issue:10

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole

2023
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
    Neurology, 2023, 03-07, Volume: 100, Issue:10

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole

2023
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
    Neurology, 2023, 03-07, Volume: 100, Issue:10

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole

2023